MA51146B1 - Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5 - Google Patents

Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5

Info

Publication number
MA51146B1
MA51146B1 MA51146A MA51146A MA51146B1 MA 51146 B1 MA51146 B1 MA 51146B1 MA 51146 A MA51146 A MA 51146A MA 51146 A MA51146 A MA 51146A MA 51146 B1 MA51146 B1 MA 51146B1
Authority
MA
Morocco
Prior art keywords
heterocyclic compounds
substituted heterocyclic
compounds used
prmt5 inhibitors
bicyclic substituted
Prior art date
Application number
MA51146A
Other languages
English (en)
Other versions
MA51146A (fr
Inventor
Venkata Palle
Rajender Kamboj
Dipak Lagad
Sanjeev Kulkarni
Prathap Nair
Ganesh Gudade
Sachin Sethi
Chetan Pawar
Mahadeo Tryambake
Chaitanya Kulkarni
Anil Hajare
Balasaheb Gore
Milind Sindkhedkar
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority claimed from PCT/IB2018/060015 external-priority patent/WO2019116302A1/fr
Publication of MA51146A publication Critical patent/MA51146A/fr
Publication of MA51146B1 publication Critical patent/MA51146B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés hétérocycliques bicycliques substitués de formule (i), des sels pharmaceutiquement acceptables de ceux-ci et des compositions pharmaceutiques pour le traitement de maladies, de troubles ou d'états pathologiques associés à la surexpression de l'enzyme prmt5. L'invention concerne également des méthodes de traitement de maladies, de troubles ou d'états pathologiques associés à la surexpression de l'enzyme prmt5.
MA51146A 2017-12-13 2018-12-13 Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5 MA51146B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201721044886 2017-12-13
PCT/IB2018/060015 WO2019116302A1 (fr) 2017-12-13 2018-12-13 Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5

Publications (2)

Publication Number Publication Date
MA51146A MA51146A (fr) 2021-03-24
MA51146B1 true MA51146B1 (fr) 2022-10-31

Family

ID=83995765

Family Applications (1)

Application Number Title Priority Date Filing Date
MA51146A MA51146B1 (fr) 2017-12-13 2018-12-13 Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5

Country Status (1)

Country Link
MA (1) MA51146B1 (fr)

Also Published As

Publication number Publication date
MA51146A (fr) 2021-03-24

Similar Documents

Publication Publication Date Title
MA43169B1 (fr) Composés héterocycliques en tant qu' inhibiteurs pi3k-gamma
MA47079B1 (fr) Composés amino-triazolopyidines et leur utilisation pour traiter le cancer
PH12020550881A1 (en) Substituted bicyclic heterocyclic compounds as prmt5 inhibitors
GEP20237561B (en) Protein tyrosine phosphatase inhibitors
MA43979B1 (fr) Dérivés de 1h-indazole-3-carboxamide et composés similaires en tant qu'inhibiteurs du facteur d pour le traitement de maladies characterisés par une activité aberrante du système complémentaire, comme p.E. Troubles immunologiques
MA44674B1 (fr) Inhibiteurs de bromodomaine
MA39554A3 (fr) Spirocycloheptanes utilisés en tant qu'inhibiteurs de rock
EA201691428A1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
MA41179A (fr) Composés inhibiteurs de parg
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
MA54133A (fr) Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y
MA46229B1 (fr) Composés d'hétéroaryle carboxamide en tant qu'inhibiteurs de ripk2
MA40955B1 (fr) 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
MA49956B1 (fr) Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
EA202192900A1 (ru) Модуляторы пути интегрированной реакции на стресс
MX2020001531A (es) Nuevos compuestos hetorociclicos como inhibidores de cdk8/19.
MA43052B1 (fr) Inhibiteurs de la kallicréine plasmatique humaine
MA41633B1 (fr) Composés amide en tant qu'agonistes du récepteur 5-ht4
MX2022003873A (es) Inhibidores de 1,6-naftiridina sustituida de cdk5.
MA53372B1 (fr) Pyridopyrimidinones comme inhibiteurs du récepteur h4 de l'histamine
MA51146B1 (fr) Composés hétérocycliques bicycliques substitués utilisés en tant qu'inhibiteurs de prmt5
MA44383B1 (fr) Un derivé de 4-(3-pyrazolylamino)-benzimidazole en tant qu'inhibiteur de jak1 pour le traitement du cancer
MA39533A1 (fr) Composés, composition pharmaceutique et leur utilisation dans le traitement de maladies neurodégénératives
EA202190452A1 (ru) Ингибиторы cdk8/19
MA46462B1 (fr) Composés substitués de pyrazolo[1,5-a]pyridine en tant qu'inhibiteurs de la kinase ret